
1 

(1) This Order may be cited as the Misuse of Drugs (Designation) (Amendment No.2) Order (Northern Ireland) 2014 and shall come into operation on 26th June 2014.
(2) The Interpretation Act (Northern Ireland) 1954  shall apply to this Order as it applies to an Act of the Northern Ireland Assembly.
2 
In Part 1 of the Schedule to the Misuse of Drugs (Designation) Order (Northern Ireland) 2001  (controlled drugs to which section 7(4) of the Misuse of Drugs Act applies), after paragraph 1(t) insert—“
(u) Any compound (not being benzyl(α-methyl-3,4-methylenedioxyphenethyl)amine) structurally derived from mescaline, 4-bromo-2,5-dimethoxy-α-methylphenethylamine, 2,5-dimethoxy-α,4-dimethylphenethylamine, N-hydroxytenamphetamine, or a compound specified in sub-paragraph (c) or (d) above by substitution at the nitrogen atom of the amino group with a benzyl substituent, whether or not substituted in the phenyl ring of the benzyl group to any extent.
(v) Any compound (not being a compound for the time being specified in sub-paragraph (c) above) structurally derived from 1-benzofuran, 2,3-dihydro-1-benzofuran, 1H-indole, indoline, 1H-indene, or indane by substitution in the 6-membered ring with a 2-ethylamino substituent whether or not further substituted in the ring system to any extent with alkyl, alkoxy, halide or haloalkyl substituents and whether or not substituted in the ethylamino side-chain with one or more alkyl substituents.”
Sealed with the Official Seal of the Department of Health, Social Services and Public Safety on 5th June 2014
Dr Liz Reaney
A senior officer of the
Department of Health, Social Services and Public Safety
